SIAH2 and cholangiocarcinoma: To test whether Siah2 may regulate antitumor T-cell immunity via regulating PD-L1, we performed in vitro T-cell–mediated killing assays in a co-culture, in which activated HPBMC were cultured in the presence of human CCA cell lines.